Literature DB >> 3133032

Beta blockers, lipids, and coronary atherosclerosis.

A Ramani, S Nayak, G N Kundaje, A R Aroor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133032      PMCID: PMC2545719          DOI: 10.1136/bmj.296.6631.1257-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  8 in total

1.  Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.

Authors:  K Chadda; S Goldstein; R Byington; J D Curb
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

Review 2.  Beta blockers and lipoproteins: a review of current knowledge.

Authors:  R J Northcote; I C Todd; D Ballantyne
Journal:  Scott Med J       Date:  1986-10       Impact factor: 0.729

3.  High-carbohydrate, high-fiber diet. Is it practical and effective in treating hyperlipidemia?

Authors:  J W Anderson; N J Gustafson
Journal:  Postgrad Med       Date:  1987-09-15       Impact factor: 3.840

4.  The effect of alcohol on serum high density lipoprotein (HDL). A controlled experiment.

Authors:  G E Fraser; J T Anderson; N Foster; R Goldberg; D Jacobs; H Blackburn
Journal:  Atherosclerosis       Date:  1983-03       Impact factor: 5.162

5.  Declining trend in mortality after myocardial infarction.

Authors:  A Aberg; R Bergstrand; S Johansson; G Ulvenstam; A Vedin; H Wedel; C Wilhelmsson; L Wilhelmsen
Journal:  Br Heart J       Date:  1984-03

6.  Effect of propranolol in postinfarction patients with mechanical or electrical complications.

Authors:  C D Furberg; C M Hawkins; E Lichstein
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

Review 7.  Thiazides, beta blockers and lipoproteins.

Authors:  D Ballantyne; F C Ballantyne
Journal:  Postgrad Med J       Date:  1983-08       Impact factor: 2.401

8.  Serum lipids in hyper- and hypothyroidism before and after treatment.

Authors:  T Friis; L R Pedersen
Journal:  Clin Chim Acta       Date:  1987-01-30       Impact factor: 3.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.